Current Investing Position
Merck Global Health Innovation Fund Managing Director
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Investments On Record
17
David Rubin is on these Sector & Stage Rankings
BioTech (Series B)Medical Devices (Series B)Medical Devices (Series A)Pharmaceuticals (Series B)BioTech (Series A)Pharmaceuticals (Series A)Health & Hospital Services (Series B)Health IT (Series A)Health & Hospital Services (Series A)Diagnostics (Series B)Diagnostics (Series A)Digital Health (Series B)Health IT (Series B)Digital Health (Series A)
David Rubin's Investments On Record (12)
Company | StageDateRound Size | Total Raised |
---|---|---|
N-Power Medicine | Series BMay 2024 | |
Baseimmune | Series AFeb 2024$11M | $17M |
Culmination Bio | Series ANov 2023$10M | $10M |
Octave | Series BJul 2023$33M Series UnknownOct 2021 | $150M |
Turbine | Series ANov 2022$21M | $130M |
PreciseDx | Series AJan 2022$11M | $14M |
Verge Genomics | Series BDec 2021$98M | $130M |
Ciox Health | Private EquityJul 2019$30M | $30M |
Investors who invest with David Rubin
Founders who looked at David Rubin's profile also looked at these Scouts & Angels